PHASE-II TRIAL OF TAXOL IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA

被引：47

作者：

EINZIG, AI

GOROWSKI, E

SASLOFF, J

WIERNIK, PH

机构：

[1] ALBERT EINSTEIN CANC CTR,BRONX,NY

[2] MONTEFIORE MED CTR,BRONX,NY 10467

来源：

CANCER INVESTIGATION | 1991年 / 9卷 / 02期

关键词：

D O I：

10.3109/07357909109044223

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Based on results of previous Phase I studies, 18 patients with documented metastastic renal cell carcinoma received Taxol 250 mg/m2 as a 24-h infusion, repeated every 21 days in this Phase II study. All patients received premedication with dexamethasone, diphenhydramine, and cimetidine. There were no responses in the 18 patients treated.

引用

页码：133 / 136

页数：4

共 17 条

[1]

DONEHOWER RC, 1987, CANCER TREAT REP, V71, P1171

[2]

GREM JL, 1987, CANCER TREAT REP, V71, P1179

[3] CURRENT STATUS OF THERAPY OF ADVANCED RENAL CARCINOMA [J].

HRUSHESKY, WJ ;

MURPHY, GP .

JOURNAL OF SURGICAL ONCOLOGY, 1977, 9 (03) :277-288

[4]

KRIS MG, 1986, CANCER TREAT REP, V70, P605

[5] PHASE-I STUDY OF TAXOL USING A 5-DAY INTERMITTENT SCHEDULE [J].

LEGHA, SS ;

TENNEY, DM ;

KRAKOFF, IR .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (05) :762-766

[6]

LONGNECKER SM, 1987, CANCER TREAT REP, V71, P53

[7] CURRENT THERAPY FOR RENAL-CELL CARCINOMA [J].

MCDONALD, MW .

JOURNAL OF UROLOGY, 1982, 127 (02) :211-217

[8]

OHNUMA T, 1985, P AM ASSOC CANC RES, V26, P167

[9] TOXICITY AND RESPONSE CRITERIA OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP [J].

OKEN, MM ;

CREECH, RH ;

TORMEY, DC ;

HORTON, J ;

DAVIS, TE ;

MCFADDEN, ET ;

CARBONE, PP .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (06) :649-655

[10] PROMOTION OF MICROTUBULE ASSEMBLY INVITRO BY TAXOL [J].

SCHIFF, PB ;

FANT, J ;

HORWITZ, SB .

NATURE, 1979, 277 (5698) :665-667

← 1 2 →